NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Metastatic colorectal cancer
Date of first enrollment	01/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Bevacizumab INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Injection

Outcome(s)

Primary Outcome	Initial safety, PK parameter of bevacizumab
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	<= 74age old
Gender
Include criteria	PS=0-2, Age < 75 yrs, with target leasion according to RECEST
Exclude criteria